Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Thymus Neoplasms 1Thymoma 1Recurrence 1Neoplasms 1Fallopian Tube Neoplasms 1Carcinoma, Ovarian Epithelial 1Carcinoma, Non-Small-Cell Lung 1

Interventions

130-nm albumin-bound paclitaxel 2selinexor 1pembrolizumab 1isophosphamide mustard 1epacadostat 1Sunitinib 1Ramucirumab 1Radiotherapy 1Radiation Dose Hypofractionation 1Paclitaxel 1Leucovorin 1Histocompatibility Testing 1Granulocyte-Macrophage Colony-Stimulating Factor 1Epirubicin 1Cyclophosphamide 1Cisplatin 1Chemoradiotherapy 1Carboplatin 168Ga-pentixafor 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Unknown × Thymoma × epacadostat × Clear all
NCT02364076 2019-12-13

Pembrolizumab and Epacadostat in Patients With Thymic Carcinoma

Georgetown University

Phase 2 Unknown
45 enrolled 10 charts
Thoracic

Thymoma, Thymus Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡